A
Alexander N. Hanania
Researcher at Baylor College of Medicine
Publications - 23
Citations - 566
Alexander N. Hanania is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 7, co-authored 18 publications receiving 329 citations. Previous affiliations of Alexander N. Hanania include University of Texas Health Science Center at Houston & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Radiation-Induced Lung Injury: Assessment and Management.
TL;DR: Current research advances include high-precision radiation techniques, an improved understanding of the molecular basis of RILI, the development of small and large animal models, and the identification of candidate drugs for prevention and treatment.
Journal ArticleDOI
Quantitative imaging to evaluate malignant potential of IPMNs.
Alexander N. Hanania,Leonidas E. Bantis,Ziding Feng,Huamin Wang,Eric P. Tamm,Matthew H.G. Katz,Anirban Maitra,Eugene J. Koay +7 more
TL;DR: HG IPMNs appear to have distinct imaging properties, and further validation of these findings may address a major clinical need in this population by identifying those most likely to benefit from surgical resection.
Journal ArticleDOI
The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
Labib Debiane,Ray Y Hachem,Iba Al Wohoush,William Shomali,Ramez Bahu,Ying Jiang,Anne Marie Chaftari,Joseph Jabbour,Munirah Al Shuaibi,Alexander N. Hanania,S. Egbert Pravinkumar,Philipp Schuetz,Issam I Raad +12 more
TL;DR: In critically ill patients with cancer, proadrenomedullin and procalcitonin both have a promising role in predicting bloodstream infections in a manner more helpful than C-reactive protein.
Journal ArticleDOI
Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach
Eugene J. Koay,Alexander N. Hanania,William A. Hall,Cullen M. Taniguchi,Neal Rebueno,Sten Myrehaug,K. Aitken,Laura A. Dawson,Christopher H. Crane,Joseph M. Herman,Beth Erickson +10 more
TL;DR: A detailed description of practical approaches to dose-escalation in pancreatic cancer is provided, including particle therapy and magnetic-resonance guided radiotherapy (MRgRT).
Journal ArticleDOI
Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection
Anne Marie Chaftari,Ray Y Hachem,Ruth Reitzel,Mary Jordan,Ying Jiang,Ammar Yousif,Kumait Garoge,Poonam Deshmukh,Zanaib Al Hamal,Joseph Jabbour,Alexander N. Hanania,Sammy Raad,Mohamed A. Jamal,Issam I Raad +13 more
TL;DR: A potential role for PCT and IL-6 in predicting cancer in non-febrile patients is suggested and PCT is useful in detecting progression of cancer and predicting bacteremia or sepsis in febrile cancer patients.